Public annual accounts

LMDB RHUMATOLOGIE financials

Name: LMDB RHUMATOLOGIE financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for LMDB RHUMATOLOGIE, with comparable measures and links to available source documents.

Company overview

Registry number

0838114543

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for LMDB RHUMATOLOGIE

2025 versus 2024

Operating line: €93,843
EBITDA: €92,997
Total assets: €295,262
Equity: €200,105

EBITDA margin +99.1% · Equity ratio +67.8%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€93,843	€92,997	€295,262	€200,105	-
202431 Dec 2024	€108,685	€107,850	€258,419	€167,052	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report